Streetbeat News

Products Services

SER

Serina Therapeutics and Enable Injection have announced a partnership to develop and commercialize SER-252 (POZ-apomorphine) in combination with Enfuse for the treatment of Parkinson's Disease.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 11:32 am

BWMN

Bowman Consulting has been selected by the Arizona Department of Transportation to provide engineering and oversight services.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 11:31 am

JSDA

Jones Soda Co. reported a 39% year-over-year revenue increase for Q1 2024, reaching $5 million, with significant contributions from its cannabis business, Mary Jones. The company is transitioning from a soda company to a high-growth beverage company, with new product offerings and strategic partnerships. Gross profit margins improved, and net loss decreased slightly. The company also secured a $2 million revolving credit facility.

Portfolio Pulse from Nina Zdinjak

May 15, 2024 | 11:25 am

BYDDY

NIO

XPEV

XPeng Inc. (NYSE:XPEV) shares are trading higher in the premarket session due to reports that the company plans to use BYD Co., Ltd. (OTC:BYDDY) batteries for its new Mona sub-brand. The Mona brand's first model, an A-class compact electric sedan, is expected to be revealed in June and delivered in the third quarter. XPeng's Zhaoqing plant has been upgraded to support the new model's production.

Portfolio Pulse from Nabaparna Bhattacharya

May 15, 2024 | 11:24 am

BDX

F

FSLR

GM

OMI

TXN

President Biden's new tariffs on Chinese imports, including a significant increase on Chinese electric vehicles, are expected to benefit U.S. automakers Ford and General Motors. Jim Cramer highlighted that these tariffs will protect American car companies from cheap Chinese competition. The tariffs will also impact other products like semiconductors and solar cells, benefiting companies such as First Solar, Texas Instruments, Owens & Minor, and Becton Dickinson.

Portfolio Pulse from Benzinga Neuro

May 15, 2024 | 11:20 am

FLGC

IMCC

Flora Growth Corp. (NASDAQ: FLGC) reported a net loss of $3.4 million for Q1 2024, with revenue of $18.03 million. The company is optimistic about cannabis reforms in the U.S. and Germany. Flora has expanded its footprint in Europe through acquisitions and distribution agreements. The stock closed 5.19% lower at $1.28 per share.

Portfolio Pulse from Nina Zdinjak

May 15, 2024 | 11:16 am

DORM

Dorman Products has announced the release of hundreds of new aftermarket automotive components and assemblies.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 11:14 am

TFFP

TFF Pharmaceuticals has provided an update on its ongoing Phase 2 trial of Tacrolimus Inhalation Powder for preventing lung transplant rejection. Patient enrollment has accelerated, with 10 patients now enrolled. All 6 patients who completed the 12-week treatment have chosen to continue in the safety extension phase. The treatment has shown reduced variability in systemic exposure to Tacrolimus, potentially lowering the risk of acute rejection and systemic toxicities.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 11:14 am

CREX

Creative Realities (CREX) has announced the development of a new channel program specifically tailored for the EMEA (Europe, Middle East, and Africa) marketplace. This strategic move aims to expand their market presence and drive growth in these regions.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 11:14 am

TRAK

ReposiTrak has announced the addition of 20 new produce suppliers to its rapidly expanding food traceability network.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 11:12 am